OTCMKTS:GNWSD StageZero Life Sciences (GNWSD) Stock Price, News & Analysis $0.0010 0.00 (0.00%) As of 10/13/2026 Add Compare Share Share Stock Analysis Stock AnalysisChart About StageZero Life Sciences Stock (OTCMKTS:GNWSD) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get GNWSD alerts:Sign Up Key Stats Today's Range$0.0010▼$0.001050-Day Range N/A52-Week Range$0.17▼$0.89VolumeN/AAverage Volume4,987 shsMarket Capitalization$48.94 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview StageZero Life Sciences is a life sciences company focused on developing and commercializing molecular diagnostic tests designed to support the detection and management of disease. Its work is centered on blood-based testing and the analysis of gene-expression patterns, with the goal of providing less invasive alternatives to conventional diagnostic procedures. The company has developed the Aristotle platform, a molecular diagnostic technology intended to identify cancer-related signals from blood samples. StageZero has also pursued diagnostic applications in areas including cancer screening and infectious disease testing, although the availability and status of particular products and programs may vary by jurisdiction. StageZero Life Sciences has historical ties to GeneNews Corporation and has operated in the biotechnology and diagnostics sector from Canada, serving healthcare providers and patients through laboratory and clinical testing initiatives. The company’s focus is on expanding access to earlier and more convenient disease detection through proprietary molecular testing technologies.AI Generated. May Contain Errors. Read More Receive GNWSD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for StageZero Life Sciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. GNWSD Stock News HeadlinesBay Area life sciences campus hits the market after $20 million renovationNovember 13, 2024 | bizjournals.comWave Life Sciences Reveals RNA Editing Breakthrough, Reports First-Ever Clinical Proof-Of-Mechanism In HumansOctober 16, 2024 | benzinga.comFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leading Weiss Ratings, the only conflict-free rating agency in the US. Now he says a $3 trillion problem could trigger a chain reaction of crashes and failures, causing a global freeze in financial markets.October 16 at 1:00 AM | Weiss Ratings (Ad)Students explore life science during USD-501′s annual Kanza Science DaysOctober 1, 2024 | msn.comHow Boy Meets World ’s Ben Savage Views Maitland Ward's Porn CareerSeptember 25, 2024 | yahoo.comIncreased vacancy rates don't tell the full story when it comes to life sciences in ChicagoSeptember 24, 2024 | bizjournals.comPlano gives incentives for multi-billion dollar life science campus at former EDS siteAugust 28, 2024 | msn.comGreensboro Science Center howler monkey dies at 27 ‘surrounded by the love of her caretakers’August 18, 2024 | msn.comSee More Headlines GNWSD Stock Analysis - Frequently Asked Questions How have GNWSD shares performed this year? StageZero Life Sciences' stock was trading at $0.0005 at the start of the year. Since then, GNWSD shares have increased by 100.0% and is now trading at $0.0010. How do I buy shares of StageZero Life Sciences? Shares of GNWSD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry N/A Sub-IndustryN/A Current SymbolOTCMKTS:GNWSD CIKN/A Webwww.stagezerolifesciences.com Phone(855) 420-7140FaxN/AEmployees80Year Founded1998Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.48 million Net Margins217.39% Pretax MarginN/A Return on EquityN/A Return on Assets-61.21% Debt Debt-to-Equity RatioN/A Current Ratio0.09 Quick Ratio0.06 Sales & Book Value Annual Sales$140 thousand Price / Sales0.35 Cash FlowN/A Price / Cash FlowN/A Book Value($0.13) per share Price / Book-0.01Miscellaneous Outstanding Shares48,940,000Free FloatN/AMarket Cap$48.94 thousand OptionableNot Optionable Beta2.97 Social Links 7 Blue-Chip Stocks to Add To Your Forever PortfolioA strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership. This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.Get This Free Report This page (OTCMKTS:GNWSD) was last updated on 10/13/2026 by MarketBeat.com Staff. From Our PartnersElon Musk’s 4th Wealth Window Set to Open by October 30Jeff Brown, the analyst who flagged Bitcoin, Tesla, and Nvidia early, is tracking Elon Musk's next move. He po...Brownstone Research | SponsoredFinancial legend: “This is bad, really bad...”Dr. Martin D. Weiss has publicly predicted six major American financial crashes over his 55-year career leadin...Weiss Ratings | SponsoredSpaceX minted 4400 millionaires in a single daySpaceX minted 4,400 millionaires in a single day, and Tesla has turned more than 5,000 employees into milliona...Behind the Markets | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredA new income category is drawing serious money - here's whyForbes recently called a new category of exchange-traded income funds a 'golden era,' and Bloomberg noted the ...Investors Alley | SponsoredUndiscovered Sub-$1 Gold-Silver Royalty Stock Takes FlightA small-cap gold and silver royalty company is generating record revenue from producing mines, yet shares stil...Digest Publishing | SponsoredINSANE DRONE FOOTAGENew drone footage shows a mysterious factory rising at one of Elon Musk's most secure facilities, cleared and ...Paradigm Press | SponsoredThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding StageZero Life Sciences Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share StageZero Life Sciences With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GNWSD Stock Alerts